1 Min Read
Dec 28 (Reuters) - Jubilant Pharma Ltd (IPO-JUBI.SI):
* JUBILANT RECEIVES SNDA APPROVAL FOR NEW INDICATIONS FROM USFDA FOR DRAXIMAGE® DTPA Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.